About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:2656301
Allelic
Composition
Seletm2Alb/Seletm2Alb
Selltm2Alb/Selltm2Alb
Selptm1Bay/Selptm1Bay
Genetic
Background
involves: 129S7/SvEvBrd * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Seletm2Alb mutation (0 available); any Sele mutation (51 available)
Selltm2Alb mutation (0 available); any Sell mutation (41 available)
Selptm1Bay mutation (3 available); any Selp mutation (56 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
N
• GM-CSF levels are comparable to levels in wild-type or Sell-null mutants; elevation observed in Sele/Selp double null mice is absent
• neutrophil influx to the peritoneal cavity during thioglycolate-induced peritonitis is significantly reduced compared to wild-type animals in this model
• rolling is severely compromised; no rolling is seen up to 5 hours after cremaster muscle exteriorization
• rolling flux and rolling fraction are more reduced than the decrease observed in Sele/Selp double null mice
• white blood cell counts (total, eosinophil, neutrophil, monocyte counts) are significantly elevated compared to wild-type, but are ~half the value found in Sele/Selp double mutants
• in liver parenchyma and sinusoids, neutrophil numbers are ~2-fold higher in mutants after Gal/ET treatment; numbers of neutrophils in liver tissue are significantly elevated 4 hours prior to Gal/ET treatment, compared to controls (J:106550)
• more neutrophils accumulate in the hepatic vascular beds (sinusoids and venules) after Gal/ET treatment in mutants than in wild-type controls (J:106550)
• moderate disruption of splenic architecture is observed
• lymphoid follicles of the white pulp are identified occasionally and have irregular shapes and sizes
• both old and young mice show severe cervical lymphadenopathy, compared to wild-type or Sell-null mice; condition is more severe than in Sele/Selp/Sell-triple null mice
• both old and young mice show marked cervical lymphadenopathy, compared to wild-type or Sell-null mice; condition is less severe than in Sele/Sell-double null mice
• both old and younger mice show bronchial lymphoid aggregates

hematopoietic system
• neutrophil influx to the peritoneal cavity during thioglycolate-induced peritonitis is significantly reduced compared to wild-type animals in this model
• rolling is severely compromised; no rolling is seen up to 5 hours after cremaster muscle exteriorization
• rolling flux and rolling fraction are more reduced than the decrease observed in Sele/Selp double null mice
• mice show moderate extramedullary hematopoiesis in sinusoid of red pulp
• white blood cell counts (total, eosinophil, neutrophil, monocyte counts) are significantly elevated compared to wild-type, but are ~half the value found in Sele/Selp double mutants
• in liver parenchyma and sinusoids, neutrophil numbers are ~2-fold higher in mutants after Gal/ET treatment; numbers of neutrophils in liver tissue are significantly elevated 4 hours prior to Gal/ET treatment, compared to controls (J:106550)
• more neutrophils accumulate in the hepatic vascular beds (sinusoids and venules) after Gal/ET treatment in mutants than in wild-type controls (J:106550)
• moderate disruption of splenic architecture is observed
• lymphoid follicles of the white pulp are identified occasionally and have irregular shapes and sizes

respiratory system
• both old and younger mice show bronchial lymphoid aggregates
• lung tissue displays decreasing cellularity within alveolocapillary walls, but this is less severe than in Sele/Selp double-nulls
• only a small increase in leukocytes in alveolocapillary walls are observed and occasional small bronchial lymphoid aggregates are found

cardiovascular system
• only a small increase in leukocytes in alveolocapillary walls are observed and occasional small bronchial lymphoid aggregates are found

liver/biliary system
• at 7 hours after galactosamine/bacterial endotoxin (Gal/ET) treatment, area on necrosis is attenuated 68% compared to treated controls
• mutants show decreased liver injury relative to treated controls at 7 hours after treatment with Gal/ET

homeostasis/metabolism
• at 7 hours after galactosamine/bacterial endotoxin (Gal/ET) treatment, plasma ALT levels are reduced by 65% compared to treated controls

integument
N
• mice do not show skin ulcerations as seen in double Sele/Selp mutants

cellular
• at 7 hours after galactosamine/bacterial endotoxin (Gal/ET) treatment, area on necrosis is attenuated 68% compared to treated controls
• neutrophil influx to the peritoneal cavity during thioglycolate-induced peritonitis is significantly reduced compared to wild-type animals in this model
• rolling is severely compromised; no rolling is seen up to 5 hours after cremaster muscle exteriorization
• rolling flux and rolling fraction are more reduced than the decrease observed in Sele/Selp double null mice


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/16/2024
MGI 6.23
The Jackson Laboratory